2015
DOI: 10.1159/000434639
|View full text |Cite
|
Sign up to set email alerts
|

Malignant Triton Tumor of the Kidney. New Location Not Previously Reported

Abstract: Malignant triton tumor (MTT) is a variant of the peripheral nerve sheath tumor. It is very uncommon but shows an aggressive course and limited survival. Half of the cases present symptoms related to neurofibromatosis type 1 disease. There is no standardized treatment, but multimodal approach is the best option. We present the case of a primary MTT located in the kidney, in a 43-year-old woman who received neoadjuvant chemotherapy as first-line treatment followed by surgical resection and adjuvant chemotherapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…This indicated that nerve sheath as well as rhabdomyoblastic components were contained in tumor. [4] MTTs can display as sporadic cases, in young patients, approximately 60% to 70% accompany with neurofibromatosis type 1 (NF1). And deregulation of p53 may play a part in the genesis of MTT.…”
Section: Discussionmentioning
confidence: 99%
“…This indicated that nerve sheath as well as rhabdomyoblastic components were contained in tumor. [4] MTTs can display as sporadic cases, in young patients, approximately 60% to 70% accompany with neurofibromatosis type 1 (NF1). And deregulation of p53 may play a part in the genesis of MTT.…”
Section: Discussionmentioning
confidence: 99%
“…[ 16 ] Recently, Gallego et al ., reported a case of malignant triton tumor of the kidney. [ 17 ] Malignant triton tumor refers to MPNSTs with rhabdomyosarcomatous differentiation characterized by both neural and skeletal muscle differentiation. [ 18 ] It is extremely rare to have two or more heterogeneous components in a single MPNST.…”
Section: Discussionmentioning
confidence: 99%
“…MTT is an aggressive tumor with a poor prognosis, affecting, in most cases, patients under 35 years of age, and the average age of incidence is 31.7 years [7] . The occurrence in pediatric patients is rare [8] , and may be sporadic or occur in conjunction with neurofibromatosis type 1 (NF1) [7] , [9] , with 50–70% of MTTs occurring in those with this genetic condition [10] , [11] . Furthermore, irradiation is considered a risk factor for the development of its sporadic form [9] .…”
Section: Introductionmentioning
confidence: 99%